CliffBio
small molecule

ADVAIR HFA

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Loss of exclusivity—loss of exclusivity
CompanyGLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE

Drug detail

Brand nameADVAIR HFA
Active ingredientFLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
Strength0.045MG/INH;EQ 0.021MG BASE/INH
Dosage formAEROSOL, METERED
RouteINHALATION
ModalitySmall molecule
FDA approvalJune 2006
Marketing statusRX

More from GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ADVAIR HFA patent cliff — loss of exclusivity — | CliffBio